Concepedia

Xiangdong Bai

XB

Statistics

Publications

7

Citations

256

H-Index

7

Active since

2011

Affiliations

Shanxi Medical University(Current)

Shanxi Provincial Cancer Hospital

Capital Medical University

Beijing Chao-Yang Hospital, Capital Medical University

Xiangdong Bai is an author at Shanxi Medical University specializing in medicine, oncology, and cancer biology.

ORCID

Publications per year

2011–2023

7

Publications

7

MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3

Xiangdong Bai, Guohui Han, Yang Liu et al. · Biomedicine & Pharmacotherapy · 2018 · 126 citations

, , +12

Cancer cell‐derived exosomal <scp>miR</scp>‐20a‐5p inhibits <scp>CD8</scp><sup>+</sup> T‐cell function and confers <scp>anti‐</scp>programmed cell death 1 therapy resistance in triple‐negative breast cancer

Weina Li, Guohui Han, Feng Li et al. · Cancer Science · 2023 · 35 citations · Full text

, , +16

Treatment of Multi‐Drug‐Resistant Tuberculosis in Mice with DNA Vaccines Alone or in Combination with Chemotherapeutic Drugs

Yan Liang, Xueqiong Wu, Jun-Quan Zhang et al. · Scandinavian Journal of Immunology · 2011 · 25 citations · Full text

, , +17

Simultaneous Preconcentration and Analysis of Anthraquinones Based on Ultrasound Emulsification Ionic Liquid Microextraction

Yinghua Yan, Xi Chen, Song Hu et al. · Journal of Chromatographic Science · 2013 · 19 citations

, , +17

Chidamide suppresses the glycolysis of triple negative breast cancer cells partially by targeting the miR‑33a‑5p‑LDHA axis

Xiangdong Bai, Hongchuan Jiang, Guohui Han et al. · Molecular Medicine Reports · 2019 · 19 citations · Full text

, , +16

1–5 of 7